In latest J&J recall, Ethicon unit pulls two products

Johnson & Johnson's Ethicon unit recently recalled 700,000 vials of a liquid wound-sealing product amid reports of discoloration and a new hernia-treatment product due to concerns about non-sterile packaging. Report

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.